The TMF Reference Model eTMF Exchange Mechanism Standard (EMS) sub-group is pleased to announce the launch of an industry survey on TMF interchange. The first version of the EMS was launched in 2019 with the goal of facilitating the interchange of TMF content between organizations and systems. The standard allows organizations to send artifacts and their related metadata and audit trail information to other organizations and systems. The goal is to greatly facilitate TMF content exchange, both during and at the end of a clinical study.
The survey will collect feedback on the use of the EMS and the future direction of the standard. The EMS team invites all industry stakeholders, including sponsors, CROs and vendors, to respond to the survey. The feedback that we collect will be published and will help define the future direction of the standard.
According to EMS Co-Chair Paul Fenton, “Improving the way we move TMF content between organizations is one of the key challenges that our industry faces. The EMS promises to help us meet this challenge. Making sure that we understand how organizations want to use the EMS standard is key to ensuring its successful adoption as well as its future evolution, and we hope to gain significant industry insight from our survey”. EMS Co-Chair Elvin Thalund said, “Successful collaboration across sponsors, sites, CROs, and ethical authorities, is today hampered by inefficient transfer of TMF content from one organization to another, and often requires that content has to be reindexed and reverified. This is where an industry TMF exchange mechanism can be the key to solve this major problem.”
The Survey will be closed on Dec 31, 2020 and the results will be shared early 2021.
About the eTMF Exchange Mechanism Standard
Sponsors and CROs who have traditionally managed their Trial Master Files (TMFs) on paper have seen significant improvements when migrating to an electronic Trial Master File (eTMF) system. However, the exchange of TMF content between sponsors, CROs and other stakeholders has remained challenging as they often use systems provided by different eTMF vendors. The TMF Reference Model has partially solved this problem. The model is an emerging standard that has provided a common structure for essential TMF documents. However, exchanging TMFs between different vendor systems remains due to the lack of a common exchange standard. The eTMF Exchange Mechanism Team, a sub-group of the TMF Reference Model project, has published the eTMF Exchange Mechanism Standard (eTMF-EMS) v1.0.1 as a specification for transferring TMF data between different eTMF systems.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.